StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.89−0.03 (-3.28%)

Close on Nov 17, 2026Market cap $50.03MP/E –Yield –

PDS Biotechnology gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for PDS Biotechnology

PDS Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More PDS Biotechnology figures

See a number that looks wrong?